Majeski James
900 Bowman Rd., Suite 100, Mt. Pleasant, SC 29464-3218, USA.
Am J Surg. 2004 Aug;188(2):168-70. doi: 10.1016/j.amjsurg.2004.03.002.
Aneurysm formation in arterialized autologous saphenous veins is an unusual complication of in situ femoral popliteal bypass procedures.
In a personal series of 207 in situ saphenous femoral popliteal bypass operations, three nonanastomatic venous aneurysms occurred. All three venous aneurysms occurred in male patients who had no adequate autologous vein available as an interposition graft. The use of eversion endarterectomized superficial femoral artery is reported as a substitute interposition graft with long-term results.
In the 3 male patients in this series, nonanastomatic aneurysms developed in their in situ saphenous femoral popliteal bypass grafts. The venous aneurysms developed between 5 and 8 years after the original surgical procedure. No adequate vein was available as a replacement for the excised venous aneurysm. Prosthetic conduit was not used owing to the remote possibility of a subclinical infection. A segment of eversion thromboendarectomized superficial femoral artery removed from the same leg was used as a replacement interposition graft in each patient. The in situ venous graft with the autologous interposition thromboendarterectomized superficial femoral artery remained patent until each patient's death 4 to 7 years after the venous aneurysm replacement.
A short segment of endarectomized superficial femoral artery has been found to be a novel solution for the treatment of isolated saphenous vein graft aneurysms when no suitable vein is available. These patients should be maintained on lifelong aspirin therapy owing to the thrombogenic potential of endarectomized artery.
动脉化自体隐静脉形成动脉瘤是原位股腘动脉搭桥手术的一种罕见并发症。
在本人的207例原位隐静脉股腘动脉搭桥手术系列中,发生了3例非吻合口静脉动脉瘤。所有3例静脉动脉瘤均发生在男性患者中,这些患者没有足够的自体静脉作为间置移植物。报告了使用外翻内膜切除术处理的股浅动脉作为替代间置移植物的长期结果。
在本系列的3例男性患者中,原位隐静脉股腘动脉搭桥移植物中出现了非吻合口动脉瘤。静脉动脉瘤在原手术5至8年后形成。没有足够的静脉可用于替代切除的静脉动脉瘤。由于存在亚临床感染的遥远可能性,未使用人工血管。从同一条腿上切除的一段外翻血栓内膜切除术处理的股浅动脉被用作每个患者的替代间置移植物。带有自体间置血栓内膜切除术处理的股浅动脉的原位静脉移植物一直保持通畅,直到每个患者在静脉动脉瘤置换术后4至7年死亡。
当没有合适的静脉可用时,已发现一段内膜切除术处理的股浅动脉是治疗孤立性隐静脉移植物动脉瘤的一种新解决方案。由于内膜切除术处理的动脉具有血栓形成潜力,这些患者应终身接受阿司匹林治疗。